Australian Diversified Financial Stock News

It is hard to get excited after looking at Simonds Group's (ASX:SIO) recent performance, when its stock has declined...

As Asian markets navigate a complex landscape of economic indicators and geopolitical tensions, small-cap stocks have emerged as an area of interest, particularly as investors seek opportunities amid fluctuating trade dynamics and monetary policies. In this environment, identifying promising small-cap stocks often involves looking at factors such as insider activity and market positioning to gauge potential resilience and growth prospects.

Maggie Beer Holdings Limited ( ASX:MBH ) insiders who bought shares over the past year were rewarded handsomely last...

We think all investors should try to buy and hold high quality multi-year winners. While the best companies are hard to...

DigitalX Limited ( ASX:DCC ) insiders who purchased shares in the last 12 months were richly rewarded last week. The...

Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at the...

While BSA Limited ( ASX:BSA ) might not have the largest market cap around , it led the ASX gainers with a relatively...

As the ASX200 flirts with record highs, investor sentiment in Australia is cautiously optimistic, buoyed by potential trade deals and corporate activities like mergers and acquisitions. In such a climate, identifying undervalued stocks becomes crucial for investors looking to capitalize on market opportunities; companies with strong fundamentals and growth potential can offer promising prospects even amidst fluctuating sector performances.

With a median price-to-earnings (or "P/E") ratio of close to 18x in Australia, you could be forgiven for feeling...

Key Insights Significantly high institutional ownership implies Flight Centre Travel Group's stock price is sensitive...

The Australian stock market is experiencing a significant upswing, with the ASX 200 reaching new heights amid optimism from positive U.S.-China trade discussions. In this context, penny stocks—often representing smaller or newer companies—continue to capture investor interest due to their affordability and growth potential. Despite being an older term, these stocks can offer substantial opportunities when backed by strong financials and solid fundamentals.

With its stock down 11% over the past three months, it is easy to disregard Champion Iron (ASX:CIA). We, however...

Key Insights Institutions' substantial holdings in Iluka Resources implies that they have significant influence over...

With a price-to-earnings (or "P/E") ratio of 5.2x Bathurst Resources Limited ( ASX:BRL ) may be sending very bullish...

Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at the...

It might seem bad, but the worst that can happen when you buy a stock (without leverage) is that its share price goes...

Key Insights Significant insider control over Redox implies vested interests in company growth The top 7 shareholders...

Key Insights Institutions' substantial holdings in Mirvac Group implies that they have significant influence over the...

Investing in stocks comes with the risk that the share price will fall. And unfortunately for Monash IVF Group Limited...

Viewing insider transactions for Clever Culture Systems Limited's ( ASX:CC5 ) over the last year, we see that insiders...

Steadfast Group's (ASX:SDF) stock is up by 7.2% over the past three months. As most would know, long-term fundamentals...

We think intelligent long term investing is the way to go. But unfortunately, some companies simply don't succeed. To...

The Australian market has recently reached new heights, with the ASX 200 setting a record high driven by strong performances in the Energy, Technology, and Financial sectors. In such a robust market environment, investors often seek opportunities that combine affordability with growth potential. Penny stocks—though an older term—still hold relevance as they typically involve smaller or newer companies that can offer significant returns when backed by solid financials.

Mesoblast (ASX:MSB) experienced a 15% increase in its share price over the past week, largely driven by a significant orphan-drug approval by the U.S. FDA for Ryoncil. This approval, granting seven years of exclusivity for a vital treatment, likely bolstered investor confidence given the strengthened competitive positioning of Mesoblast. While broader market trends saw the S&P 500 and Nasdaq reach new highs amid positive investor sentiment on U.S.-China trade discussions, Mesoblast's specific...